Chimera Virus Constructed for Potential New Lymphoma Therapy
Published:21 Sep.2017 Source:GEN
Scientists from the Instituto de Medicina Molecular (iMM) Lisboa in Portugal say in collaboration with Harvard Medical School, they have created a chimeric virus that allows them to study novel approaches to treat cancer caused by human herpesvirus infection in a mouse model.
A team led by iMM's Pedro Simas, Ph.D., and Kenneth Kaye, M.D., studied a Kaposi virus protein vital for maintaining infection named LANA, or latency-associated nuclear antigen, without which the virus can't cause cancer.